Cargando…
RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progression
Androgen receptor (AR) signaling drives prostate cancer (PC) progression. Androgen deprivation therapy (ADT) is temporally effective, whereas drug resistance inevitably develops. Abnormal expression of AR/ARV7 (the most common AR splicing variant) is critical for endocrine resistance, while the deta...
Autores principales: | Zhou, Tingting, Wang, Shengli, Song, Xiaoyu, Liu, Wensu, Dong, Fang, Huo, Yunlong, Zou, Renlong, Wang, Chunyu, Zhang, Siyi, Liu, Wei, Sun, Ge, Lin, Lin, Zeng, Kai, Dong, Xiang, Guo, Qiqiang, Yi, Fei, Wang, Zhuo, Li, Xiaoman, Jiang, Bo, Cao, Liu, Zhao, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012884/ https://www.ncbi.nlm.nih.gov/pubmed/35428760 http://dx.doi.org/10.1038/s41419-022-04787-9 |
Ejemplares similares
-
The Functions of DNA Damage Factor RNF8 in the Pathogenesis and Progression of Cancer
por: Zhou, Tingting, et al.
Publicado: (2019) -
PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells
por: Liu, Wei, et al.
Publicado: (2021) -
An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer
por: Sun, Ge, et al.
Publicado: (2020) -
RNF8 induces β-catenin-mediated c-Myc expression and promotes colon cancer proliferation
por: Ren, Ling, et al.
Publicado: (2020) -
BAP18 coactivates androgen receptor action and promotes prostate cancer progression
por: Sun, Shiying, et al.
Publicado: (2016)